Dr. Bapi Gorain

Ph.D.

Date of Joining: 18th October, 2021
  • Q. No. CII/34, Outer Campus, BIT Mesra, Ranchi 835215, Jharkhand
  • 9088585676
    |
    9088585676

Research Areas

  • Nanopharmacology and toxicology

Work Experience

  • Teaching: 10.6 Years
  • Research: 15.6 Years
  • Industry: 18.6 Years
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--faculty.html.twig ✅ field--node--title.html.twig ▪️ field--node--faculty.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- BEGIN OUTPUT from 'themes/contrib/bootstrap_barrio/templates/field/field--node--title.html.twig' --> <span class=Bapi " width="406" height="371" loading="lazy" >

Academic Profile

Award and Honours
Award and Honours

10

Total Award and Honours
Project
Project

12

Total Project

Leadership & Institutional Service

Teaching & Mentorship

Award and Honours

View All

Guest Editorship in the journal “Journal of Food Process Engineering” of Wiley Publishers under the theme of the special issue “Sustainable Processing Technologies for Food Securities, Public Health and Nutrition”-2025

Delivered an invited talk on “Thermosensitive in situ gelling system of different varieties of Indian honey targeting wound tissue regeneration” in the International Conference on Nano-Structured Materials and Nanocomposites (ICN 2025), September 12-14, 2

“Innovations in Translational Therapy and Targeted Drug Delivery (ITTD-2025)” during September 1–4, 2025, organised by the Nanomedicine Research Laboratory, Department of Pharmacy, BITS Pilani-Hyderabad Campus.

Current Sponsored Projects

View All
  • 1. Start-up Research Grant entitled "Mechanistic insight of healing diabetic wound by different varieties of honey via regulating the expression of adenosine monophosphate-activated protein kinase (AMPK), hypoxia inducible factor-1α (HIF-1α) and inflammat
  • 2. Seed Money Project entitled "Wound healing potential of naringin via regulating the expression of adenosine monophosphate-activated protein kinase (AMPK) and hypoxia inducible factor-1α (HIF-1α) in experimentally induced diabetic animals" from Birla In
  • 4. “Tailoring bioactive nano-constituent embedded fish waste-derived collagen/polycaprolactone nanofiber to promote rapid hemostasis in the management of traumatic conditions” from Indian Council of Medical Research, Govt. of India, New Delhi, India.
  • Status: Completed

Intellectual Property Rights (IPR)

View All

  • Bi-layered nanofiber scaffold for enhanced hemostatic and wound care applications and related methods

    • Date:

  • Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agents. Patent No

    • Date:

  • Thieno [2, 3-d] pyrimidines as COX-2 inhibitors. Patent No. US patent: 11932656, Grant date: Date: 19.03.2024. Inventors: Katharigatta N Venugopala, Pran Kishore Deb, Raghu Prasad Mailavaram, Nizar A Al-Shar'i, Swastika Ganguly, Bapi Gorain, Lim Tse Mun,

    • Date: